Skip to main content
Clinical Trials/NCT06563219
NCT06563219
Completed
Not Applicable

Comparative Analysis of Traditional Clinical Scores and Combined Grading Systems in Predicting 28-Day Mortality in Non-Traumatic Subarachnoid Hemorrhage

Haseki Training and Research Hospital1 site in 1 country451 target enrollmentStarted: September 1, 2020Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Haseki Training and Research Hospital
Enrollment
451
Locations
1
Primary Endpoint
Predictive ability of modified Fisher scale for 28-day mortality

Overview

Brief Summary

The investigators investigated the predictive ability of clinical and radiological scores, including the Glasgow coma scale (GCS), Hunt-Hess, World Federation of Neurological Surgeons (WFNS), and modified Fisher scales, as well as combined clinical scores such as the VASOGRADE and Ogilvy-Carter rating scales, for 28-day mortality in patients presenting to the emergency department (ED) with non-traumatic subarachnoid hemorrhage (SAH). Specifically, we tested the hypothesis that combined clinical scores are more reliable and superior to non-combined clinical and radiological scores in predicting 28-day mortality in non-traumatic SAH.

Detailed Description

Patients were divided into survivors and non-survivors, with surviving patients further categorized as either mobile or immobile based on the Glasgow outcome scale. Accordingly, patients who were dependent on daily support or in a coma were classified as immobile, whereas patients who had returned to normal life or were independent in their daily activities were classified as mobile. The demographic (age and sex), comorbidities (hypertension, diabetes mellitus [DM] and/or coronary artery disease [CAD]), vital signs (systolic blood pressure, heart rate, respiratory rate, and peripheral capillary oxygen saturation [sPO2]), and clinical assessment tools (GCS, Hunt Hess, WFNS, modified Fisher, VASOGRADE, and Ogilvy-Carter rating scales) on admission were compared between the groups to identify factors associated with 28-day mortality and neurological survival. Independent predictors of mortality were determined by multivariate logistic regression analysis of variables (demographic characteristics, clinical characteristics, and trauma scores) that differed significantly between survivors and non-survivors. An area under the curve (AUC) analysis was then conducted to identify which trauma score is the most reliable and superior predictor of mortality.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients (aged ≥ 18 years) who presented to the emergency department with non-traumatic Subarachnoid Hemorrhage between September 2020 and September 2023

Exclusion Criteria

  • patients younger than 18 years
  • patients with missing information
  • patients with traumatic SAH
  • patients with subdural or epidural hemorrhage
  • patients with concurrent ischemic stroke

Outcomes

Primary Outcomes

Predictive ability of modified Fisher scale for 28-day mortality

Time Frame: From admission to 28 days

The investigators assessed the predictive ability of modified Fisher scale in determining 28-day mortality.

Predictive ability of Ogilvy-Carter rating scale for 28-day mortality

Time Frame: From admission to 28 days

The investigators assessed the predictive ability of Ogilvy-Carter rating scale in determining 28-day mortality.

Predictive ability of Glasgow coma scale for 28-day mortality

Time Frame: From admission to 28 days

The investigators assessed the predictive ability of Glasgow coma scale in determining 28-day mortality.

Predictive ability of World Federation of Neurological Surgeons (WFNS) scale for 28-day mortality

Time Frame: From admission to 28 days

The investigators assessed the predictive ability of World Federation of Neurological Surgeons (WFNS) scale in determining 28-day mortality.

Predictive ability of Hunt-Hess scale for 28-day mortality

Time Frame: From admission to 28 days

The investigators assessed the predictive ability of Hunt-Hess scale in determining 28-day mortality.

Predictive ability of VASOGRADE scale for 28-day mortality

Time Frame: From admission to 28 days

The investigators assessed the predictive ability of VASOGRADE scale in determining 28-day mortality.

Secondary Outcomes

  • Predictive ability of modified Fisher scale for neurological survival(From admission to 28 days)
  • Predictive ability of World Federation of Neurological Surgeons (WFNS) scale for neurological survival(From admission to 28 days)
  • Predictive ability of Ogilvy-Carter rating scale for neurological survival(From admission to 28 days)
  • Predictive ability of Glasgow coma scale for neurological survival(From admission to 28 days)
  • Predictive ability of Hunt-Hess scale for neurological survival(From admission to 28 days)
  • Predictive ability of VASOGRADE scale for neurological survival(From admission to 28 days)

Investigators

Sponsor
Haseki Training and Research Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Adem Az

Principal Investigator

Haseki Training and Research Hospital

Study Sites (1)

Loading locations...

Similar Trials